US EditionMan sees deadly brain tumour shrink by half thanks to new radioactive therapy
- A man has seen his deadly brain tumour shrink by half thanks to a new radioactive therapy, which experts hope will eradicate the disease.
- Paul Read, a 62-year-old engineer from Luton, is the first patient to take part in the trial and has seen his tumour shrink in half in a matter of weeks.
- Dr. Paul Mulholland, UCLH consultant medical oncologist who designed the trial, said the reduction of Mr. Read's tumour 'is really quite remarkable for somebody whose tumour is so aggressive.'
- Researchers plan to combine ATT001 with immunotherapy, which trains the body's immune system to kill cancerous cells.
Insights by Ground AI
Does this summary seem wrong?
16 Articles
16 Articles
All
Left
2
Center
2
Right
4
Coverage Details
Total News Sources16
Leaning Left2Leaning Right4Center2Last UpdatedBias Distribution50% Right
Bias Distribution
- 50% of the sources lean Right
50% Right
L 25%
C 25%
R 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
